Series C · Healthtech
Neurent Medical: Series C
Develops NEUROMARK, a minimally invasive solution to treat chronic rhinitis
Funding history
Series C · This round€62.5M
Loading rounds…
Develops NEUROMARK, a minimally invasive solution to treat chronic rhinitis